← Back to the disclosure log

Who in Congress Has Traded Bristol-Myers Squibb Company (BMY)?

The Bristol-Myers Squibb Company line shows up 119 times in the congressional disclosure record between 2013 and 2026, filed by 35 members: 66 purchases against 53 sales. On balance the chamber has been net buyers, and the purchases sit up 17.4% against the latest close.

119Trades
66Buys
53Sells
35Members
$66.58Latest close 2026-08-28
+17.4%Congress buys vs latest close*

*Purchases only, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings report a range, never a share count, so this follows the stock rather than anyone's position size.

55% buys45% sells

How it splits by party

Republicans
42 buys · 40 sells
20 members · 82 trades
Democrats
23 buys · 10 sells
12 members · 33 trades

Whose BMY buys have done best

Members ranked by how their reported BMY purchases have moved since, over roughly the last three years, weighted by disclosed band midpoint and marked to the latest close.

1 Thomas H Tuberville
+21.8%
2 Alan Armstrong
+13.7%
3 Virginia Foxx
+12.1%
DateMemberTypeAmountEst. priceLatest closeReturn
2026-05-07Mike KellySELL$15K–$50K$56.25$66.58 2026-08-28-7.3% rt
2026-03-27Alan ArmstrongBUY$1K–$15K$58.54$66.58 2026-08-28+13.7%
2025-06-24Virginia FoxxSELL$1K–$15K$47.03$66.58 2026-08-28-20.8% rt
2025-04-15Thomas H TubervilleSELL$1K–$15K$50.00$66.58 2026-08-28-33.2% exit
2025-04-15Thomas H TubervilleSELL$1K–$15K$50.00$66.58 2026-08-28-33.2% exit
2024-12-06Virginia FoxxBUY$1K–$15K$59.38$66.58 2026-08-28+12.1%
2024-04-03Thomas H TubervilleSELL$1K–$15K$52.18$66.58 2026-08-280.0% rt
2024-04-03Thomas H TubervilleBUY$1K–$15K$52.18$66.58 2026-08-28+27.6%
2024-01-09Rick LarsenSELL$1K–$15K$51.28$66.58 2026-08-28-18.4% rt
2024-01-03Thomas H TubervilleSELL$1K–$15K$52.30$66.58 2026-08-28-27.3% exit
2023-11-16Thomas H TubervilleSELL$1K–$15K$50.84$66.58 2026-08-28-11.4% rt
2023-10-17Thomas H TubervilleBUY$1K–$15K$57.37$66.58 2026-08-28+16.1%
2023-08-22Daniel S SullivanSELL$1K–$15K$61.86$66.58 2026-08-28-7.6% exit
2023-08-22Daniel S SullivanSELL$1K–$15K$61.86$66.58 2026-08-28-7.6% exit
2023-05-10Shelley M CapitoSELL$1K–$15K$68.49$66.58 2026-08-28+2.8% exit
2023-01-10Daniel S SullivanSELL$1K–$15K$71.65$66.58 2026-08-28+7.1% exit
2022-11-28Nicholas V. TaylorSELL$100K–$250K$79.14$66.58 2026-08-28+15.9% exit
2022-11-08Kurt SchraderBUY$1K–$15K$79.98$66.58 2026-08-28-16.8%
2022-06-17Shelley M CapitoSELL$1K–$15K$73.77$66.58 2026-08-28+9.8% exit
2022-01-18Thomas R CarperBUY$1K–$15K$64.89$66.58 2026-08-28+2.6%
2021-11-29Thomas R CarperBUY$1K–$15K$54.64$66.58 2026-08-28+21.9%
2021-11-10Carol Devine MillerSELL$15K–$50K$59.39$66.58 2026-08-28-12.1% exit
2021-10-28Kim Dr SchrierSELL$1K–$15K$57.13$66.58 2026-08-28-16.5% exit
2021-09-23John A. YarmuthBUY$1K–$15K$60.63$66.58 2026-08-28+9.8%
2021-09-22John A. YarmuthBUY$1K–$15K$60.15$66.58 2026-08-28+10.7%
2020-12-30Thomas R CarperBUY$1K–$15K$61.92$66.58 2026-08-28+7.5%
2020-11-25Rick LarsenBUY$1K–$15K$62.84$66.58 2026-08-28+6.0%
2020-07-21John RutherfordBUY$1K–$15K$59.80$66.58 2026-08-28+11.3%
2020-06-21John RutherfordBUY$1K–$15K$56.41$66.58 2026-08-28+18.0%
2020-04-16David A Perdue , JrSELL$1K–$15K$59.56$66.58 2026-08-28-11.8% exit
2020-04-16David A Perdue , JrSELL$1K–$15K$59.56$66.58 2026-08-28-11.8% exit
2020-04-14David A Perdue , JrSELL$15K–$50K$60.04$66.58 2026-08-28+35.9% rt
2020-04-14David A Perdue , JrSELL$15K–$50K$60.04$66.58 2026-08-28+6.5% rt
2020-04-14Kelly LoefflerSELL$250K–$500K$60.04$66.58 2026-08-28-10.9% exit
2020-04-14Kelly LoefflerSELL$100K–$250K$60.04$66.58 2026-08-28-10.9% exit
2020-04-03Katherine M. ClarkBUY$1K–$15K$55.53$66.58 2026-08-28+19.9%
2020-03-13Nicholas Van TaylorSELL$100K–$250K$54.99$66.58 2026-08-28-21.1% exit
2020-03-04George HoldingBUY$1K–$15K$61.48$66.58 2026-08-28+8.3%
2020-01-21Mikie SherrillBUY$1K–$15K$67.43$66.58 2026-08-28-1.3%
2019-12-18Mikie SherrillSELL$1K–$15K$63.15$66.58 2026-08-28+39.1% rt
2019-11-26Gilbert CisnerosSELL$1K–$15K$56.73$66.58 2026-08-28+25.2% rt
2019-08-15David A Perdue , JrSELL$15K–$50K$45.75$66.58 2026-08-28-25.0% rt
2019-07-25Mikie SherrillBUY$1K–$15K$45.40$66.58 2026-08-28+46.6%
2019-07-15David A Perdue , JrBUY$15K–$50K$44.19$66.58 2026-08-28+50.7%
2019-07-10John RutherfordSELL$1K–$15K$45.96$66.58 2026-08-28-44.9% exit
2019-04-23Gilbert CisnerosBUY$1K–$15K$45.32$66.58 2026-08-28+46.9%
2018-12-28Sheldon WhitehouseSELL$15K–$50K$50.94$66.58 2026-08-28+4.1% rt
2018-11-26John A. YarmuthSELL$1K–$15K$52.73$66.58 2026-08-28-14.3% rt
2018-09-14Mike KellyBUY$1K–$15K$60.69$66.58 2026-08-28+9.7%
2018-06-08Carlos CurbeloSELL$1K–$15K$53.16$66.58 2026-08-28-12.7% rt

Buys are marked to the latest close and treated as open. A sell tagged rt closes an earlier disclosed buy in the same name. exit shows how the stock moved after the member sold.

Next →

Frequently asked — Bristol-Myers Squibb Company (BMY) congressional trades

Which lawmakers have traded Bristol-Myers Squibb Company (BMY)?

35 members of the U.S. House and Senate have disclosed Bristol-Myers Squibb Company transactions under the STOCK Act — 66 purchases and 53 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.

Which lawmakers bought BMY recently?

No member of Congress has disclosed a BMY purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.

How have Congress's BMY trades performed?

Notional-weighted, lawmakers' disclosed BMY buys are up 17.4% versus the latest close of $66.58. Each trade's own return — and realized round-trips on matched sells — is in the Return column.

Is it legal for members of Congress to trade Bristol-Myers Squibb Company?

Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded BMY and how it performed.

Related stocks — also traded by the same lawmakers

MSFT 30AAPL 25CSCO 24JNJ 24PFE 23AMZN 23XOM 22T 22DIS 22CVX 22CVS 22PG 21MRK 21GE 20WFC 20PEP 20GOOGL 20CMCSA 20